Circumcision devices versus standard surgical techniques in adolescent and adult male circumcisions: a Cochrane review.

#Andrology circumcision male meta-analysis systematic review

Journal

BJU international
ISSN: 1464-410X
Titre abrégé: BJU Int
Pays: England
ID NLM: 100886721

Informations de publication

Date de publication:
07 2022
Historique:
received: 06 09 2021
accepted: 21 09 2021
pubmed: 30 9 2021
medline: 2 7 2022
entrez: 29 9 2021
Statut: ppublish

Résumé

To assess the effects of device-based circumcisions compared with standard surgical techniques in adolescent and adult males (10 years old and above). We performed a comprehensive search with no restrictions to the language of publication or publication status. We included randomised controlled trials (RCTs) of device-based circumcisions compared to standard surgical dissection-based circumcision conducted by health professionals in a medical setting. We reported study results as risk ratios (RRs) or mean differences (MDs) using 95% confidence intervals (CIs) and a random-effects model. We used the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach to evaluate the overall certainty of the evidence for each outcome. A total of 18 trials met the inclusion criteria. These trials did not report severe adverse events (AEs; 11 trials, 3472 participants). There may be a slight increase in moderate AEs for devices compared to surgical techniques (RR 1.31, 95% CI 0.55-3.10; I We found no serious AEs using a circumcision device compared to surgical techniques. Still, they may slightly increase moderate AEs, and it is unclear whether there is a difference in mild AEs. High-quality trials evaluating this intervention are needed to provide further certainty regarding the rates of AEs. Clinicians, patients, and policymakers can use these results combined with their contextual factors to inform the best approach that suits their healthcare settings.

Identifiants

pubmed: 34587354
doi: 10.1111/bju.15604
pmc: PMC9297972
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

26-34

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2021 The Authors. BJU International published by John Wiley & Sons Ltd on behalf of BJU International.

Références

BJU Int. 2005 Nov;96(7):1109-13
pubmed: 16225538
Cochrane Database Syst Rev. 2021 Mar 31;3:CD012250
pubmed: 33786810
World J Clin Pediatr. 2017 Feb 8;6(1):89-102
pubmed: 28224100
J Acquir Immune Defic Syndr. 2014 Apr 1;65(4):447-55
pubmed: 24583615
Transl Androl Urol. 2014 Mar;3(1):113-24
pubmed: 26816759
Urology. 2015 Apr;85(4):799-804
pubmed: 25711156
Asian J Androl. 2014 May-Jun;16(3):453-6
pubmed: 24759586
Med Sci Monit. 2014 Mar 20;20:454-62
pubmed: 24647226
J Acquir Immune Defic Syndr. 2016 Jun 1;72 Suppl 1:S1-4
pubmed: 27331583
Int J Surg. 2017 Jul;43:17-25
pubmed: 28522221
J Acquir Immune Defic Syndr. 2012 Sep 1;61(1):49-55
pubmed: 22739133
Obstet Gynecol Surv. 2004 May;59(5):379-95
pubmed: 15097799
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120
Zhonghua Nan Ke Xue. 2010 Apr;16(4):325-7
pubmed: 20626160
Stat Med. 2002 Jun 15;21(11):1539-58
pubmed: 12111919
J Acquir Immune Defic Syndr. 2013 Oct 1;64(2):130-3
pubmed: 23599013
S Afr Med J. 2009 Mar;99(3):163-9
pubmed: 19563093
S Afr Med J. 2013 Jun 05;103(10):736-42
pubmed: 24079625
Zhonghua Nan Ke Xue. 2015 Apr;21(4):330-3
pubmed: 26027100
PLoS One. 2016 May 26;11(5):e0156220
pubmed: 27227679
BMJ. 2007 Dec 8;335(7631):1206-90
pubmed: 18063645
Cochrane Database Syst Rev. 2009 Apr 15;(2):CD003362
pubmed: 19370585
Asian J Androl. 2017 May-Jun;19(3):362-367
pubmed: 26975486
Zhonghua Nan Ke Xue. 2014 Sep;20(9):816-9
pubmed: 25306810
PLoS One. 2016 Jun 14;11(6):e0157065
pubmed: 27299735
Asian J Androl. 2008 May;10(3):447-54
pubmed: 18385906
Exp Ther Med. 2017 Jul;14(1):298-302
pubmed: 28672929
Sci Rep. 2016 May 09;6:25514
pubmed: 27156368
BMJ. 2008 May 3;336(7651):995-8
pubmed: 18456631
Zhonghua Nan Ke Xue. 2015 Apr;21(4):334-7
pubmed: 26027101
Braz J Med Biol Res. 2015 Jun;48(6):577-82
pubmed: 25831203
S Afr Med J. 2013 Nov 20;104(1):52-7
pubmed: 24388090

Auteurs

Ameer Steven-Jorg Hohlfeld (AS)

Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa.

Sumayyah Ebrahim (S)

Department of Surgery, School of Clinical Medicine, University of KwaZulu-Natal, Durban, South Africa.

Muhammed Zaki Shaik (M)

Department of Surgery, School of Clinical Medicine, University of KwaZulu-Natal, Durban, South Africa.

Tamara Kredo (T)

Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa.
Clinical Pharmacology Division, Department of Medicine, Stellenbosch University, Cape Town, South Africa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH